Activation of macrophages by bacterial lipopolysaccharide (LPS) 
Upon exposure to bacterial lipopolysaccharide (LPS), a conserved component of the Gram-negative bacterium's outer membrane, macrophages release a large number of immunoregulatory molecules including tumor necrosis factor a, interleukin 1 (IL-1), , and arachidonic acid metabolites that recruit and activate other immune cells to help fight the bacterial infection (1, 2) . The mechanism by which LPS induces these events is only partly understood. At physiological concentrations, LPS binds to the serum protein LPS-binding protein (LBP) . This complex then interacts with CD14 on macrophages or neutrophils (3) . Although CD14 is a glycosylphosphatidylinositol-linked protein that lacks an intracellular domain, LPS-LBP binding to CD14 results in rapid phosphorylation of various proteins on tyrosyl residues (3) . Inhibitors of this protein tyrosine phosphorylation response abrogate cytokine secretion and generation of eicosinoids (3) , emphasizing the importance of this event in mediating the macrophage response to LPS. Among the most prominently tyrosinephosphorylated proteins in LPS-stimulated macrophages are three members of the mitogen-activated protein (MAP) kinase family, a group of related serine/threonine protein kinases that participate in transmitting extracellular signals to the cell The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
interior, including the nucleus (4, 5) . The LPS-activated MAP kinases include p42/extracellular signal-regulated kinase 2 (ERK2), p44/ERK1, and p38, the (11) . Murine bone marrow-derived macrophages were isolated and cultured in medium containing 20% L-cell-conditioned medium as described (13, 14) . After at least 6 days in vitro, the murine bone marrow cells were seeded onto 100-mm plates and grown to 60-80% confluency for experiments. Examination of cellular responses and lysis conditions were as described (11, 12) .
Immunoprecipitation and Kinase Assay. Triton X-100-soluble protein lysates were precleared with protein ASepharose (Pharmacia) and then incubated with anti-JNK antibody overnight at 4°C. The immunoprecipitates were washed twice with lysis buffer and once with kinase assay buffer (25 mM Hepes, pH 7.4/20 mM MgCl2/20 mM P-glycerophosphate/0.1 mM sodium orthovanadate/2 mM dithiothreitol). Immunocomplex kinase assays were performed as described (15) with the exception that reactions were performed at 30°C for 15 min using [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] ,tg of GST or GST-c-Jun substrate.
In-Gel Kinase Assay. The kinase activity of JNK was also assessed by an in-gel kinase assay, wherein GST-c-Jun, the JNK substrate, was copolymerized into the polyacrylamide gel as described (16) .
Transient Transfection. The AP-1 luciferase reporter plasmid, AP-lLux, was generously provided by G. Crabtree (Stanford University, Palo Alto, CA). This plasmid, derived from X3CAT, contains the luciferase gene under the transcriptional control of three synthetic AP-1 sites and the simian virus 40 early promoter (17) . For transfection experiments, RAW 264.7 cells were dislodged from tissue culture dishes with a rubber policeman and transiently transfected in suspension using DEAE-dextran as described (18 (Fig. 3A) . This induced activity was detectable at 100 pg/ml and was maximal at 1 ig/ml (Fig. 3B) .
LPS-induced JNK activation also occurred in murine bone marrow-derived macrophages and in the human monocyte cell line THP-1 (Fig. 4) (24) . To determine whether the LPS-induced phosphorylation of GST-c-Jun by anti-JNK immunoprecipitates was due to p46JNK or p54JNK or both, the anti-JNK immunoprecipitates were subjected to an in-gel kinase assay, wherein proteins were resolved on an SDS/ polyacrylamide gel containing GST-c-Jun and then renatured and allowed to phosphorylate the substrate in situ (16) . As shown in Fig. 6 (3) . Moreover, antibodies directed against CD14 inhibit LPS induction of protein tyrosine phosphorylation and secretion of various cytokines (3). We therefore tested whether the ability of LPS to activate JNK in monocyte/macrophage cells was also mediated by CD14. The human monocytic THP-1 cells were pretreated with various concentrations of the anti-CD14 mAb 60b (IgG1), which prevents LPS-LBP complexes from binding to CD14 (26) and inhibits LPS-induced tyrosine phosphorylation in these cells (12) . Cells were then stimulated with LPS at various doses, after which JNK activation was assessed by the immune complex kinase assay. Inhibition of JNK activation was complete when the cells were incubated with at least 5 jtg of anti-CD14 antibody per ml prior to LPS stimulation ( Fig. 5; data not shown) . Moreover, pretreatment of the THP-1 cells with 60b mAb at 5 and 10 ,tg/ml inhibited JNK activation at all doses of LPS tested ( Fig. 5 ; data not shown). Pretreatment of these cells with other anti-CD14 mAbs blocked ERK2 phosphorylation only at low concentrations of LPS treatment (<10 ng/ml), whereas the 60b antibody blocked at low as well as high concentrations of LPS treatment (ref. 12 ; data not shown). These observations likely reflect different properties of these anti-CD14 blocking antibodies. Pretreatment of the THP-1 cells with 10 ,ug of 60b per ml did not block the activation of ERK2 by PMA (data not shown), and pretreatment with an isotype-matched control antibody did not inhibit the LPS-induced activation of JNK (Fig. 5B) (11, 23) . Therefore, activation of Raf-1 or the ERK pathway are not sufficient to activate JNK in macrophages. In contrast, PMA treatment did result in increased AP-1-mediated transactivation, although it was slower than that seen upon LPS treatment. Thus, it may be that AP-1 activity could be increased in two ways, one of which was independent of JNK activation. As (29) , whereas it is primarily proinflammatory cytokines and environmental stress that result in p38 activation (22) . The JNK pathway is also activated by cytokines and cellular stress (5) , as well as by costimulation of T lymphocytes (30) , and activation of small GTPases (31 (5) . Activated ERK also phosphorylates NF-IL6, which mediates induction of various genes, such as IL-6 and IL-8 (32) (33) (34) (35) . Activation of JNK, on the other hand, results in phosphorylation of the transcription factors c-Jun and activating transcription factor 2 (ATF2) (36) , which, in turn, mediate regulation of the AP-1 complex and c-jun promoter (5) . While it appears that these pathways are distinct signaling cascades, they may also converge on particular targets, such as the transcription factors Elk-1 (37) and c-Jun (38) . Thus 
